During the past decade, Azienda Ospedaliero-Universitaria Careggi; S.O.D. Oculistica conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliero-Universitaria Careggi; S.O.D. Oculistica" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero-Universitaria Careggi; S.O.D. Oculistica" are "Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Macular Edema" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Azienda Ospedaliero-Universitaria Careggi; S.O.D. Oculistica" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliero-Universitaria Careggi; S.O.D. Oculistica" are "Drug" (5 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (3 trials), "Lampalizumab" (1 trials) and "No intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliero-Universitaria Careggi; S.O.D. Oculistica" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Azienda Ospedaliero-Universitaria Careggi; S.O.D. Oculistica". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Azienda Ospedaliero-Universitaria Careggi; S.O.D. Oculistica, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliero-Universitaria Careggi; S.O.D. Oculistica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".